Takeda to buy out Abbott in U.S. joint venture, source says

03/19/2008 | Bloomberg1 · Reuters

Japanese drugmaker Takeda Pharmaceutical Co. Ltd. is reportedly trying to buy Abbott Laboratories' 50% stake in their U.S. venture for $5 billion. The companies declined to comment on the rumored buyout, which would have Takeda taking over TAP Pharmaceutical Products, but with Abbott getting the venture's prostate cancer division and the rights to some of Takeda's drug candidates.

View Full Article in:

Bloomberg1 · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA